Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on October 1, 2025
Verano Secures US $75,000,000 Revolving Credit Facility
Company draws US $50,000,000 to retire US $50,000,000 of its existing senior secured credit facility CHICAGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis …
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
TORONTO and HOUSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as …
Apollo Silver Announces $20.88 Million Private Placement Offering
VANCOUVER, British Columbia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo Silver” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a non-brokered private placement offering of up to 5,800,000 units (the “ …
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
APOLLO BEACH, Fla. and HUNTINGTON, W.Va., Oct. 01, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic …
Trident Resources Initiates Exploration Program at Greywacke and Hailstone Properties in Saskatchewan
Vancouver, BC, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce it is launching a geological mapping and geochemical sampling program at its 100%-owned Greywacke and …
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on positive data from multinational Phase III study in …
Mirasol Signs Agreement for the Sale of the Sascha-Marcelina Projects in Argentina for US$1.5 Million Plus Royalty
Pursuit Minerals to acquire the Sascha-Marcelina Projects for a total consideration of ~US$1.5 million Mirasol will retain a 1.5% NSR royalty. Pursuit may buy back the first 0.75% within two years for US$1.5 million, and the remaining 0.75% within three …
Appointment of Managing Director and Chief Executive Officer
ASX/TSX CODE: PRU CAPITAL STRUCTURE: Ordinary shares: 1,351,166,409 Performance rights: 8,618,344 REGISTERED OFFICE: Level 2 437 Roberts Road Subiaco WA 6008 Telephone: +61 8 6144 1700 www.perseusmining.com DIRECTORS: Rick Menell Non-Executive Chairman …